Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [225Ac]Ac-DOTA-TDA-Lipiodol® against hepatic tumors

• Váldodahkkit: Anders Josefsson (Dahkki), Angel G. Cortez (Dahkki), Harikrishnan Rajkumar (Dahkki), Joseph D. Latoche (Dahkki), Ambika P. Jaswal (Dahkki), Kathryn E. Day (Dahkki), Mohammadreza Zarisfi (Dahkki), Lora H. Rigatti (Dahkki), Ziyu Huang (Dahkki), Jessie R. Nedrow (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SpringerOpen, 2023-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background The liver is a common site for metastatic disease for a variety of cancers, including colorectal cancer. Both primary and secondary liver tumors are supplied through the hepatic artery while the healthy liver is supplied by the portal vein. Transarterial radioembolization (TARE)...